Form 4: Scilex Holding Co. Reports Stock Dividend Distribution

Scilex Holding Co. has distributed a stock dividend of Semnur Pharmaceuticals, Inc. common stock to its shareholders and holders of warrants and convertible notes.

Summary

• Scilex Holding Co. reported a stock dividend distribution on June 15, 2026.
• The dividend consisted of 13,972,900 shares of common stock of Semnur Pharmaceuticals, Inc. (SMNR).
• These shares were held by Scilex Holding Co. and distributed to record holders of Scilex Holding Co.'s common stock, warrants, and convertible notes as of June 1, 2026.
• An aggregate of 6,938,163 dividend shares are being held in abeyance for holders of warrants and convertible notes who may be entitled to them upon exercise or conversion.
• Scilex Holding Co. will file additional Form 4 reports for distributions to these 'Additional Participating Holders' upon their exercise or conversion.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral, primarily reporting a standard corporate action (stock dividend distribution) with some administrative complexities regarding shares held in abeyance.

Positives

• Distribution of Semnur Pharmaceuticals, Inc. shares to shareholders and holders of related securities.
• Fulfillment of previously announced stock dividend obligations.

Negatives

• A significant portion of the dividend shares (6,938,163) are being held in abeyance, indicating potential complexities or pending actions for certain holders.
• The need for future Form 4 filings suggests ongoing administrative processes related to the dividend distribution.

Risks

• Potential for disputes or delays in the distribution of shares held in abeyance to 'Additional Participating Holders' if exercise or conversion terms are not met.
• Administrative burden and potential for errors in tracking and distributing the abeyance shares.

Future Outlook

Scilex Holding Co. will file additional Form 4 reports to reflect the distribution of dividend shares currently held in abeyance to 'Additional Participating Holders' upon their exercise or conversion of warrants and convertible notes.

Management Comments

• Henry Ji, Scilex Holding Company, Chief Executive Officer, President and Chairperson signed the filing.
• Henry Ji, Scilex, Inc., Chief Executive Officer and President signed the filing.

Industry Context

StockSavvy.ai notes that dividend distributions, especially those involving shares of another publicly traded entity, are common corporate actions aimed at returning value to shareholders and can impact the perceived value and liquidity of both the distributing and the distributed company's stock.

Stakeholder Impact

• Shareholders of Scilex Holding Co. receive shares of Semnur Pharmaceuticals, Inc., potentially increasing their investment portfolio's diversification and value.
• Holders of Scilex Holding Co. warrants and convertible notes are beneficiaries of the dividend, with their entitlement contingent on future exercise or conversion.
• Semnur Pharmaceuticals, Inc. sees an increase in its publicly traded shares, which could affect its stock price and market capitalization.

Next Steps

• Filing of additional Form 4 reports for distributions to 'Additional Participating Holders' upon exercise or conversion of warrants and convertible notes.

Key Dates

Keywords

Scilex Holding Co, Semnur Pharmaceuticals, Stock Dividend, Form 4, SEC Filing, Beneficial Ownership, Warrants, Convertible Notes, Shareholder Distribution